COVID shot boosters for all adults will help to reduce confusion, FDA says
By
Alicia Lasek
Nov 22, 2021
The FDA “heard loud and clear” that a simpler booster strategy was needed, its vaccine chief says. But the action may be too late to head off a winter virus surge, observers say.
Nursing home providers help to design, refine facility IP program
By
Alicia Lasek
Apr 26, 2023
In partnership with providers, an infection control peer coaching program has been updated to improve its utility amid competing facility priorities and staffing shortages.
FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...
Medical cannabis may help seniors taper opioids for chronic pain: study
By
Alicia Lasek
Feb 01, 2023
Patients’ daily opioid doses were reduced by up to 51% of baseline 8 months after receiving a medical cannabis prescription, researchers found.
Nursing home staff vaccinations get a boost thanks to New York mandate; delta ups jabs nationwide
By
Alicia Lasek
Sep 29, 2021
By midnight of its Monday deadline, New York state saw vaccination rates rise to 92% among nursing home and hospital workers, according to a new report.
Dehydration plagues nursing home residents with COVID in facility study
By
Alicia Lasek
Sep 16, 2021
Clinically significant dehydration is very common among residents with COVID-19 — especially those with dementia or delirium, investigators found. Care providers should be ready with IV fluids and a...
FDA advisers vote unanimously to endorse Novavax’s COVID-19 vaccine
By
Alicia Lasek (f3)
Jun 08, 2022
Independent advisers have voted 21 to 0 to recommend the authorization of Novavax’s COVID-19 protein-based vaccine for pandemic emergency use.
Town hall meetings reveal vaccine misinformation ‘widespread’ among SNF staff
By
Alicia Lasek
Mar 29, 2021
“Outspoken” staff members from 50 skilled nursing facilities shared their vaccine concerns with investigators in a series of meetings this winter. The speed of vaccine development and infertility-...
FDA calls for investigation into its approval of controversial Alzheimer’s drug
By
Alicia Lasek
Jul 12, 2021
The acting chief of the Food and Drug Administration has called for an investigation into the events leading up to the approval of Biogen’s brain plaque-clearing dementia drug aducanumab (Aduhelm).
Fracture prevention lacking for older women, post-acute care study finds
By
Alicia Lasek
Jun 05, 2023
Across all post-acute care settings, there was low use of DXA screening and of medications to prevent bone loss — both before admittance and after discharge, researchers found.